Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 5Medulloblastoma 5Neuroblastoma 4Squamous Cell Carcinoma of Head and Neck 3Mouth Neoplasms 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Ganglioneuroblastoma 3Carcinoma 3Vulvar Neoplasms 2Gallbladder Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Vomiting 1Teratoma 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Sertoli-Leydig Cell Tumor 1Rhabdoid Tumor 1Recurrent Uterine Corpus Carcinoma 1Ovarian gynandroblastoma 1Ovarian Neoplasms 1Osteosarcoma 1Oropharyngeal Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Nausea 1Lymphoid Interstitial Pneumonia 1Hodgkin Disease 1Hepatoblastoma 1HIV Infections 1Granulosa cell tumor of the ovary 1

Interventions

Specimen Handling 2Irinotecan 2dehydroftorafur 1Watchful Waiting 1Vincristine 1Sorafenib 1Platinum 1Oxaliplatin 1Observation 1Gemcitabine 1Fluorouracil 1Etoposide 1Doxorubicin 1DT2216 1Cisplatin 1Carboplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Fibrolamellar hepatocellular carcinoma × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT03533582 2025-12-22

Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

Children's Oncology Group

Phase 3 Active not recruiting
537 enrolled
Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡